Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NR1H4 | Q96RI1 | 1/20 | 0.62 |
| ▸ | PPARA | Q07869 | 11/20 | 0.53 |
| ▸ | NPC1 | O15118 | 1/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.52 |
| ▸ | GAA | P10253 | 1/20 | 0.52 |
| ▸ | MAPT | P10636 | 3/20 | 0.52 |
| ▸ | MEN1 | O00255 | 2/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.52 |
| ▸ | PPARG | P37231 | 4/20 | 0.46 |
| ▸ | PPARD | Q03181 | 3/20 | 0.46 |
| ▸ | POLB | P06746 | 1/20 | 0.44 |
| ▸ | CLK1 | P49759 | 1/20 | 0.44 |
| ▸ | AHR | P35869 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6603227 | 0.93 | MAPT (0.58) | NR1H4PPARANPC1ALDH1A1GAA | |
| SCHEMBL6604459 | 0.90 | MAPT (0.52) | NR1H4NPC1MAPTMEN1KMT2A | |
| SCHEMBL6606889 | 0.90 | PARP1 (0.51) | NR1H4NPC1ALDH1A1GAAMAPT | |
| SCHEMBL6602409 | 0.89 | MAPT (0.51) | NR1H4NPC1ALDH1A1GAAMAPT | |
| SCHEMBL6607020 | 0.89 | NR1H4 (0.62) | NR1H4PPARANPC1ALDH1A1GAA | |
| SCHEMBL6605515 | 0.85 | NR1H4 (0.53) | NR1H4PPARANPC1ALDH1A1GAA | |
| SCHEMBL6603223 | 0.81 | KMT2A (0.58) | NR1H4PPARANPC1ALDH1A1GAA | |
| SCHEMBL6603157 | 0.80 | MAPT (0.53) | NR1H4PPARAALDH1A1MAPTMEN1 | |
| SCHEMBL6603843 | 0.80 | NR1H4 (0.54) | NR1H4PPARANPC1ALDH1A1GAA | |
| SCHEMBL6604450 | 0.78 | ROCK1 (0.54) | NR1H4NPC1MAPTMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1102535-A4 | COMPOUNDS AND METHODS | SMITHKLINE BEECHAM CORP (US) | 2004-09-29 | — | — | EP | disclosed |
| EP-1102535-A2 | COMPOUNDS AND METHODS | SmithKline Beecham Corporation (US) | 2001-05-30 | — | — | EP | disclosed |
| WO-2000006085-A2 | COMPOUNDS AND METHODS | SMITHKLINE BEECHAM CORPORATION (US) | 2000-02-10 | — | — | WO | disclosed |